Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 24

Results For "virus"

495 News Found

Wacker, CordenPharma to produce mRNA vaccines for Germany
News | April 12, 2022

Wacker, CordenPharma to produce mRNA vaccines for Germany

Both companies have been selected for stand-by production by German government


One-dose HPV vaccine offers solid protection against cervical cancer
News | April 12, 2022

One-dose HPV vaccine offers solid protection against cervical cancer

This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls


Data indicates homeopathy effective in management of long Covid
News | April 10, 2022

Data indicates homeopathy effective in management of long Covid

Dr. Kalyan Banerjee's Clinic developed a homeopathy prophylaxis protocol for the prevention of Covid-19 as soon as the pandemic began


Cadila Pharma launches world’s first three-dose rabies vaccine
News | April 08, 2022

Cadila Pharma launches world’s first three-dose rabies vaccine

The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.


CDSCO approves Phase II/III trial of Akston Bio’s Covid vaccine candidate in India
Biotech | April 08, 2022

CDSCO approves Phase II/III trial of Akston Bio’s Covid vaccine candidate in India

Veeda Clinical Research will submit data in an application for Emergency Use Authorisation


New ultra-sensitive lyo-ready PCR reagents unlock lower detection limits in lyophilised multiplex diagnostic assays
Biotech | April 07, 2022

New ultra-sensitive lyo-ready PCR reagents unlock lower detection limits in lyophilised multiplex diagnostic assays

The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format


Gufic Biosciences receives DCGI approval for Thymosin Alpha-1 to treat Covid-19
Drug Approval | April 06, 2022

Gufic Biosciences receives DCGI approval for Thymosin Alpha-1 to treat Covid-19

Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 clinical trial in adult patients with moderate-to-severe Covid-19


Merck expands manufacturing facility in Virginia to increase HPV vaccine supply
Biotech | April 04, 2022

Merck expands manufacturing facility in Virginia to increase HPV vaccine supply

Supply increase to help meet growing global demand


New data indicate molnupiravir eliminates Covid-19 rapidly
Biotech | April 03, 2022

New data indicate molnupiravir eliminates Covid-19 rapidly

Among patients with infectious virus at baseline, no patients who received Lagevrio had infectious virus at days 3, 5 or 10


WHO selects Biological E for mRNA tech transfer
News | April 03, 2022

WHO selects Biological E for mRNA tech transfer

Primarily set up to address the Covid-19 emergency, the WHO technology transfer hub has the potential to expand manufacturing capacity for other products as well, including treatments, and target other priorities such as malaria, HIV and cancer